Lifeboat Foundation

Every three seconds, a person somewhere in the world breaks a bone due to osteoporosis—a progressive disease that decreases bone density, making bones weak and fragile. Osteoporotic fractures greatly reduce quality of life, and immobilization following a fracture can lead to further bone loss which puts these patients at risk for breaking another bone.

When SpaceX CRS-11 launched to the space station last June, it carried 40 mice to the ISS National Lab for a mission aimed at improving treatment for the millions of people with osteoporosis back on Earth. The Rodent Research (RR)-5 mission successfully proved the robustness of a new potential osteoporosis therapy based on a naturally produced protein, NELL-1, and also led to significant improvements in the delivery of the therapy.

As far as humans are concerned, Mars has two stories. One is in the present: We’re trying to send our ships and our astronauts to the Red Planet in order to understand what it’s like today. But much of that work is meant to tell a second story—what the planet used to be like.

A team of OpenAI robots beat amateur human players at Dota 2.

Policymakers and analysts are digging into the details of how to get more EVs on the road.

Dreeming big.

Dreem Announces $35 Million Financing from lead investors Johnson & Johnson Innovation and Bpifrance (press release):

“Dreem, a neurotechnology company, today announced the closing of a new round of funding, raising $35 million USD to rapidly accelerate product development, invest in strategic research and development, and advance the future of sleep technology. Last year, Dreem introduced a comprehensive solution to address a suite of sleep problems and enhance the quality of rest during the night. The Dreem headband monitors brain activity to track sleep accurately and uses auditory stimulation as a medium to help people fall asleep faster, get deeper sleep, and wake up refreshed.

Continue reading “Sleep-focused neurotech firm Dreem raises $35M from Johnson&Johnson Innovation and Bpifrance” »

Ocasio-Cortez’s 100%-renewable plan puts her in agreement with a coalition of US mayors who have committed to the goal of complete decarbonization within their own cities. But Ocasio-Cortez, who has an economics degree, also couples that plank with an economic plan she is calling the Green New Deal.

In a major upset on Tuesday night, Alexandria Ocasio-Cortez, a 28-year-old Latina democratic socialist from the Bronx, beat out the longtime US representative Joe Crowley in the New York primaries. In the overwhelmingly Democratic district, she is practically certain to win a seat in Congress during the general election in November.

Ocasio-Cortez’s climate-change platform would become the most progressive of that of any sitting Congressperson in the Democratic party—and her primary victory catapults that platform into the mainstream.

Continue reading “Ocasio-Cortez’s climate plan is the only one that matches scientific consensus on the environment” »

Kroger Co. is about to test whether it can steer supermarket customers away from crowded grocery aisles with a fleet of diminutive driverless cars designed to lower delivery costs.

The test program announced Thursday could make Kroger the first U.S. grocer to make deliveries with robotic cars that won’t have a human riding along to take control in case something goes wrong.

Cincinnati-based Kroger is teaming up with Nuro, a Silicon Valley startup founded two years ago by two engineers who worked on self-driving cars at Google. That Google project is now known as Waymo, which plans to introduce a ride-hailing service that is supposed to begin picking up passengers in fully autonomous cars by the end of this year.

Continue reading “Kroger to test grocery deliveries with driverless cars” »

An interview with regenerative medicine luminary Dr. Anthony Atala.

After meeting him at the Astana Global Challenges Summit 2018, we’ve kindly been granted an interview by Dr. Anthony Atala, M.D., Director of the Wake Forest Institute for Regenerative Medicine and the W. Boyce Professor and Chair of Urology at Wake Forest University.

Dr. Atala is one of the most influential names in the field of regenerative medicine and biotechnology. His research focuses on growing human cells and tissues for use in transplants, and given the constant dire need for organ donors worldwide, his work is poised to improve—and save—the lives of millions. He and his team have already successfully engineered and transplanted bladders into living patients, and as he’s told us himself, more types of tissue have been engineered and tested in models; hopefully, they will one day be usable in patients as well.

Continue reading “Dr. Anthony Atala — Wake Forest Institute for Regenerative Medicine” »

IT’S a moment of conception on an interstellar scale. Australian astronomers have watched the death — and rebirth — of a distant solar system. Now they’re watching its embryonic nebula form.

Professor Lisa Harvey-Smith of the CSIRO has told the annual meeting of the Astronomical Society of Australia hosted at Swinburne University this week that the opportunity to observe the climactic phase in the life cycle of a star was extraordinary.

Continue reading “Astronomers capture moment of interstellar conception” »